Report cover image

Biotech Ingredients Market by Source (Bacteria, Fungi, Yeast), Application (Cosmetics, Fragrances, Personal Care) - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 05, 2023
Length 191 Pages
SKU # IRE18313294

Description

Biotech Ingredients Market by Source (Bacteria, Fungi, Yeast), Application (Cosmetics, Fragrances, Personal Care) - Global Forecast 2023-2030


The Biotech Ingredients Market is projected to reach USD 72.93 billion by 2030 from USD 43.37 billion in 2022, at a CAGR of 6.71% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biotech Ingredients Market.
  • Based on Source, market is studied across Bacteria, Fungi, and Yeast. The Fungi is projected to witness significant market share during forecast period.
  • Based on Application, market is studied across Cosmetics, Fragrances, and Personal Care. The Personal Care is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biotech Ingredients Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biotech Ingredients Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biotech Ingredients Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Biotech, Amyris, Inc., AstraZeneca PLC, Becton Dickinson and Company, bioMérieux SA, Bloomage Biotechnology Corp., Ltd., Boehringer Ingelheim International GmbH, Contipro a.s., Eli Lilly and Company, Evolva Holding SA, Evonik Industries AG, Firmenich SA by Koninklijke DSM N.V., Givaudan SA, Hayashibara Co., Ltd. by NAGASE & CO., LTD., International Flavors & Fragrances Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Sollice Biotech, Symrise AG, T. HASEGAWA CO., LTD., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Biotech Ingredients Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Biotech Ingredients Market?
  3. What is the competitive strategic window for identifying opportunities in the Biotech Ingredients Market?
  4. What are the latest technology trends and regulatory frameworks in the Biotech Ingredients Market?
  5. What is the market share of the leading vendors in the Biotech Ingredients Market?
  6. Which modes and strategic moves are suitable for entering the Biotech Ingredients Market?


Note: PDF & Excel + Online Access - 1 Year

Table of Contents

191 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biotech Ingredients Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing consumer awareness about health benefits of biotech ingredients
5.1.1.2. Rising government initiatives for biotechnology industry
5.1.2. Restraints
5.1.2.1. Limited availability & volatile prices of raw materials
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities in the field of biotechnology
5.1.3.2. Increasing biotech ingredients demand from the cosmetic & personal care industry
5.1.4. Challenges
5.1.4.1. Manufacturing complexities associated with the biotech ingredients
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Biotech Ingredients Market, by Source
6.1. Introduction
6.2. Bacteria
6.3. Fungi
6.4. Yeast
7. Biotech Ingredients Market, by Application
7.1. Introduction
7.2. Cosmetics
7.3. Fragrances
7.4. Personal Care
8. Americas Biotech Ingredients Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Biotech Ingredients Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Biotech Ingredients Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Advanced Biotech
12.1.3. Amyris, Inc.
12.1.4. AstraZeneca PLC
12.1.5. Becton Dickinson and Company
12.1.6. bioMérieux SA
12.1.7. Bloomage Biotechnology Corp., Ltd.
12.1.8. Boehringer Ingelheim International GmbH
12.1.9. Contipro a.s.
12.1.10. Eli Lilly and Company
12.1.11. Evolva Holding SA
12.1.12. Evonik Industries AG
12.1.13. Firmenich SA by Koninklijke DSM N.V.
12.1.14. Givaudan SA
12.1.15. Hayashibara Co., Ltd. by NAGASE & CO., LTD.
12.1.16. International Flavors & Fragrances Inc.
12.1.17. Merck & Co., Inc.
12.1.18. Novartis AG
12.1.19. Pfizer Inc.
12.1.20. Sanofi S.A.
12.1.21. Sollice Biotech
12.1.22. Symrise AG
12.1.23. T. HASEGAWA CO., LTD.
12.1.24. Teva Pharmaceutical Industries Ltd.
12.1.25. Viatris Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us